Prevalence of anthelmintic resistant cyathostomins in Prince Edward Island, Canada

Bellaw, 2018, Anthelmintic therapy of equine cyathostomin nematodes - larvicidal efficacy, egg reappearance period, and drug resistance, Int. J. Parasitol., 48, 97, 10.1016/j.ijpara.2017.08.009 Bello, 2009, Comparison of two fecal egg recovery techniques and larval culture for cyathostomins in horses, J. Am. Vet. Med. Assoc., 9, 1161, 10.2460/javma.234.9.1161 Boersema, 1991, The prevalence of anthelmintic resistance of horse strongyles in the Netherlands, Vet. Q., 13, 209, 10.1080/01652176.1991.9694310 Canever, 2013, Lack of Cyathostomin sp. reduction after anthelmintic treatment in horses in Brazil, Vet. Parasitol., 194, 35, 10.1016/j.vetpar.2012.12.020 Cringoli, 2017, The Mini-FLOTAC technique for the diagnosis of helminth and protozoan infections in humans and animals, Nat. Protoc., 12, 1723, 10.1038/nprot.2017.067 Denwood, 2019, A hypothesis testing framework for the ratio of means of two negative binomial distributions: classifying the efficacy of anthelmintic treatment against intestinal parasites, arXiv: Methodology Drudge, 1966, Control of internal parasites of the horse, J. Am. Vet. Med. Assoc., 148, 378 Drudge, 1982, Pyrantel in horses, Vet. Med. Small Anim. Clin., 957 Kaplan, 2004, Prevalence of anthelmintic resistant cyathostomes on horse farms, J. Am. Vet. Med. Assoc., 225, 903, 10.2460/javma.2004.225.903 Kaspar, 2017, Detection of Strongylus vulgaris in equine faecal samples by real-time PCR and larval culture – method comparison and occurrence assessment, BMC Vet. Res., 13 Larsen, 2011, Determination of ivermectin efficacy against cyathostomins and Parascaris equorum on horse farms using selective therapy, Vet. J., 188, 44, 10.1016/j.tvjl.2010.03.009 Lester, H.E., Spanton, J., Stratford, C.H., Bartley, D.J., Morgan, E.R., Hodgkinson, J.E., Coumbe, K., Mair, T., Swan, B., Lemon, G., Cookson, R., Matthews, J.B., 2013. Anthelmintic efficacy against cyathostomins in horses in Southern England. Vet. Parasitol. 197 (1-2), 189-196. doi:10.1016/j.vetpar.2013.06.009. Love, 1999, Pathogenicity of cyathostome infection, Vet. Parasitol., 85, 113, 10.1016/S0304-4017(99)00092-8 Lyons, 2009, Probable reason why small strongyle EPG counts are returning "early" after ivermectin treatment of horses on a farm in Central Kentucky, Parasitol. Res., 104, 569, 10.1007/s00436-008-1231-x Lyons, 2010, Critical tests evaluating efficacy of moxidectin against small strongyles in horses from a herd for which reduced activity had been found in field tests in Central Kentucky, Parasitol. Res., 107, 1495, 10.1007/s00436-010-2025-5 M’Aburi, 1995 Mair, 2000, Caecocaecal and caecocolic intussusceptions associated with larval cyathostomosis in four young horses, Equine Vet. J., 32, 77, 10.1111/j.2042-3306.2000.tb05339.x Newby, 1982, Field test evaluation of pyrantel pamoate paste against strongyle infections in horses, Equine practice, 4, 26 Nielsen, 2012, Strongylus vulgaris associated with usage of selective therapy on Danish horse farms—is it reemerging?, Vet. Parasitol., 189, 2, 10.1016/j.vetpar.2012.04.039 Nielsen, 2013 Nielsen, 2020, Importation of macrocyclic lactone resistant cyathostomins on a US thoroughbred farm, Int. J. Parasitol. Drugs Drug Resist., 14, 99, 10.1016/j.ijpddr.2020.09.004 Peregrine, 2006, Larval cyathostominosis in horses in Ontario: an emerging disease?, Can. Vet. J., 47, 80 Peregrine, 2014, Anthelmintic resistance in important parasites of horses: does it really matter? Vet, Parasitol., 201, 1 Reid, 1995, Epidemiological risk factors associated with a diagnosis of clinical cyathostomiasis in the horse, Equine Vet. J., 27, 127, 10.1111/j.2042-3306.1995.tb03048.x Relf, 2014, Anthelmintic efficacy on UK thoroughbred stud farms, Int. J. Parasitol., 44, 507, 10.1016/j.ijpara.2014.03.006 Sangster, 1999, Pharmacology of anthelmintic resistance in cyathostomes: will it occur with the avermectin/milbemycins?, Vet. Parasitol., 85, 189, 10.1016/S0304-4017(99)00099-0 Santos, 2018, Identification of third stage larval types of cyathostomins of equids: an improved perspective, Vet. Parasitol., 260, 49, 10.1016/j.vetpar.2018.08.007 Smith, 2015, Efficacy of major anthelmintics for reduction of fecal shedding of strongyle-type eggs in horses in the mid-Atlantic region of the United States, Vet. Parasitol., 214, 139, 10.1016/j.vetpar.2015.09.025 Stratford, 2014, An investigation of anthelmintic efficacy against strongyles on equine yards in Scotland, Equine Vet. J., 46, 17, 10.1111/evj.12079 Tarigo-Martinie, 2001, Prevalence and clinical implications of anthelmintic resistance in cyathostomes of horses, J. Am. Vet. Med. Assoc., 218, 1957, 10.2460/javma.2001.218.1957 Torgerson, 2014, Evaluating faecal egg count reduction using a specifically designed package “eggCounts” in R and a user friendly web interface, Int. J. Parasitol., 44, 299, 10.1016/j.ijpara.2014.01.005 Traversa, 2009, Anthelmintic resistance in cyathostomin populations from horse yards in Italy, United Kingdom and Germany, Parasit. Vectors, 2, S2, 10.1186/1756-3305-2-S2-S2 Tydén, 2019, Prevalence of Strongylus vulgaris in horses after ten years of prescription usage of anthelmintics in Sweden, Vet. Parasitol X, 2 Tzelos, T., Barbeito, J.S.G., Nielsen, M.K., Morgan, E.R., Hodgkinson, J.E., Matthews, J.B.,2017. Strongyle egg reappearance period after moxidectin treatment and its relationship with management factors in UK equine populations. Vet. Parasitol. 237, 70–76. van Loon, 1995, Larval cyathostomiasis as a cause of death in two regularly dewormed horses. Journal of veterinary medicine, Series A, 42, 301 Vidyashankar, 2007, Statistical approach to measure the efficacy of anthelmintic treatment on horse farms, Parasitology, 134, 2027, 10.1017/S003118200700340X Vidyashankar, 2012, Statistical and biological considerations in evaluating drug efficacy in equine strongyle parasites using fecal egg count data, Vet. Parasitol., 185, 45, 10.1016/j.vetpar.2011.10.011 Wang Wang, 2018, Modelling anthelmintic resistance by extending eggCounts package to allow individual efficacy, Int. J. Parasitol. Drugs Drug Resist., 8, 10.1016/j.ijpddr.2018.07.003